VOYA Investment Management
CCCC icon

VOYA Investment Management’s C4 Therapeutics CCCC Stock Holding History

VOYA Investment Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.6K Buy
+19,392
New +$66.3K ﹤0.01% 2365
2025
Q2 		– Sell
-17,322
Closed -$27.7K – 2665
2025
Q1 		$27.7K Sell
17,322
-955
-5% -$2.85K ﹤0.01% 2601
2024
Q4 		$65.8K Sell
18,277
-1,204
-6% -$5.99K ﹤0.01% 2652
2024
Q3 		$111K Sell
19,481
-254
-1% -$1.53K ﹤0.01% 2638
2024
Q2 		$91.2K Buy
+19,735
New +$118K ﹤0.01% 2689
2023
Q2 		– Sell
-16,458
Closed -$51.7K – 2935
2023
Q1 		$51.7K Hold
16,458
– – ﹤0.01% 2796
2022
Q4 		$97.1K Hold
16,458
– – ﹤0.01% 2762
2022
Q3 		$144K Buy
16,458
+1,297
+9% +$13.5K ﹤0.01% 2693
2022
Q2 		$114K Hold
15,161
– – ﹤0.01% 2582
2022
Q1 		$368K Hold
15,161
– – ﹤0.01% 2086
2021
Q4 		$488K Buy
15,161
+297
+2% +$11.7K ﹤0.01% 2030
2021
Q3 		$664K Buy
14,864
+1,304
+10% +$55.8K ﹤0.01% 1866
2021
Q2 		$513K Buy
+13,560
New +$486K ﹤0.01% 2069

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VOYA Investment Management's CCCC Position: Q2 2026 in Review

VOYA Investment Management opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 19,392 shares worth $90.6K. The stake represents ﹤0.01% of the portfolio and ranks #2365 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in CCCC as recently as Q1 2025.

VOYA Investment Management first reported a position in CCCC in Q2 2021 and has held it in 13 quarters since. The position peaked at $664K in Q3 2021. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • VOYA Investment Management held 19,392 shares of C4 Therapeutics worth $90.6K as of Q2 2026.
  • C4 Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2365 holding.
  • VOYA Investment Management first reported a position in C4 Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • VOYA Investment Management's C4 Therapeutics position peaked at $664K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.